SPVS is leading a ground-breaking new project which aims to find out how veterinary surgeons are treating a range of clinical conditions.
Two hundred practitioners are being sought to provide details of how they address clinical conditions in three study areas: small animal, equine and farm animal, on a new website: www.howdoido.org. The findings, which will be made anonymous, will eventually form the basis of a clinical benchmarking process, which will tie in with the growing trend towards evidence-based medicine.
SPVS's objective is to understand and support how clinicians work in practice and approach particular clinical cases. The Society is working alongside Dr Mark Johnson who carried out the Confidential Enquiry into Perioperative Equine Fatalities.
SPVS Junior Vice President Jacqui Molyneux said: "This is an exciting new study which will shed a lot of light on what we as clinicians are doing in practice with the eventual aim of developing a clinical benchmarking process.
"The project however will only be worthwhile if a significant number of practitioners take part, so we're encouraging vets to visit the website and find out more. It will take no longer than ten minutes to fill in each clinical case."
Intervet/Schering-Plough Animal Health has announced the launch of Nuflor Minidose - a 50% more concentrated, but less viscous solution of its proven Nuflor antibiotic.
Nuflor Minidose is licensed for the treatment and prevention of bacterial BRD. Intervet/Schering-Plough Animal Health livestock veterinary adviser Rosemary Booth MRCVS said: "It delivers all the rapid efficacy entrusted in Nuflor, but at a lower volume. Whereas a 20ml dose of Nuflor will treat a 150kg animal, the same volume of Nuflor Minidose will cover a 225kg beast. Compared with Nuflor, the new Minidose formulation is easier to administer delivering a less viscous florfenicol solution, with a 62% improvement in viscosity at 15°C and 59% at 5°C."
Rosemary added that Nuflor Minidose is effective against the main bacterial causes of pneumonia: P. multocida, M. haemolytica and H. somni. "Florfenicol is the only antibiotic offering 100% sensitivity to these three key BRD causes in recent trials and its kill effect also ensures that within 24 hours bacteria levels are low enough to prevent any re-growth."
She also pointed out that the new, more concentrated florfenicol solution presents vets with an improved batch treatment option for controlling BRD considering Nuflor is recognised as an effective metaphylactic
"Batch treatment prevents BRD from spreading. Trials with Nuflor have demonstrated the benefit of metaphylactic batch treatment of sick calves in a pen once at least 20% of the animals exhibit disease symptoms. Nuflor was significantly more efficacious than a control in preventing the spread of BRD in healthy calves exposed to infected animals," she explains.
"The bacteria responsible for BRD are found in the respiratory tract of healthy cattle and stress or a greater pathogen load - such as exposure to sick calves - can easily trigger disease. BRD bacterial numbers can double every 30 minutes and in 24 hours, one bacterium can multiply to billions. Batch treatment kills the bacteria before they multiply, release toxins and cause permanent lung damage."
New Nuflor Minidose is licensed for injection subcutaneously for the prevention of BRD at a dose rate of 4ml/45kg and has a 64-day meat withdrawal period.
The RCVS has announced that registrations for the new RCVS Register of Veterinary Practice Premises will be accepted from 1 November 2008, allowing all those who wish to supply medicines from veterinary practice premises from 1 April 2009 onwards a full five months to comply with the latest medicines legislation.
In order to fulfil its obligations under European law to maintain and improve traceability of, and accountability for, veterinary medicines, the UK Government decided that any veterinary surgeon may only supply veterinary medicinal products (VMPs) from premises registered with the Secretary of State, with effect from 1 April 2009.
The Veterinary Medicines Directorate (VMD) is responsible for the inspection and registration of practices under the Veterinary Medicines Regulations. Steve Dean, VMD's Chief Executive, says the new veterinary practice premises register will complete the UK information base by bringing veterinary practices in line with other suppliers of veterinary medicines who already have to operate from registered premises.
The Register will enable the supply of veterinary medicines by veterinary surgeons, including controlled drugs, to be subjected to inspection and verification. As a result, DEFRA Ministers and the European Commission can be re-assured that veterinary medicines are being supplied in the UK in accordance with EC legislation.
In discussion with the VMD, it was agreed that the most appropriate body to maintain this register would be the RCVS, not least because the College already manages the RCVS Practice Standards Scheme and publishes the (voluntary) Directory of Veterinary Practices, so has the necessary systems already in place. The register will be published on RCVSonline and updated quarterly.
Whilst there will now be a statutory fee levied for each practice premises registered on the new Register, the College's existing database framework has kept this to a relatively low £40 compared to what other bodies might have had to charge after starting from scratch.
Practices could appear in the Directory for free because the cost of producing it was partially covered by subsequent data sales. However, the new Register will need to be self-funding, as the data it contains will be freely available online.
Not all practices will have to pay the statutory fee. RCVS President Jill Nute said: "For those practice premises already accredited under the RCVS Practice Standards Scheme (PSS), the fee will be taken from their existing PSS annual fee.
"What's more, accredited practices will not face additional four-yearly inspections by VMD inspectors (unless there is an investigation for enforcement purposes) as their PSS inspections already ensure that they keep up to date with current medicines legislation."
Practice premises that have applied to join the Scheme, but have not yet been accredited, will not face additional VMD inspections either, but will still need to pay the statutory fee.
To help practices understand the new requirements and what they need to do before next April, the RCVS has produced a range of guidance, including a series of Frequently Asked Questions (www.rcvs.org.uk).
"In particular, we hope this guidance will help to explain which premises are likely to be considered ‘veterinary practice premises' and the difference between those premises and places where medicines might simply be stored or kept," said Mrs Nute.
"It is important to realise that there is a legal requirement to register veterinary practice premises for the supply of medicines, and a professional obligation, set out in the Guide to Professional Conduct, to keep a record of where all medicines are stored or kept. This record should avoid the need for additional registration of car boots, farms and homes."
Over the coming weeks, application forms will be posted to all practices currently listed in the Directory and accredited under the PSS, containing all the practice information currently held. These forms must be checked, signed and returned, even if no fee is due. Separate application forms will be available for any non-accredited practice premises not published in the Directory, and a letter will be sent to all RCVS members to ensure the whole profession is aware of the new requirements.
The European Society of Feline Medicine (ESFM) is expanding the scope and reach of its Journal of Feline Medicine and Surgery (JFMS) in January 2009 by moving to a monthly schedule and introducing six colourful new clinical issues which will alternate with the now well-established classic issues.
JFMS, the official journal of both ESFM and of the American Association of Feline Practitioners (AAFP), has an excellent citation index and is ever-growing with record numbers of high quality papers being received. The clinical issues of JFMS will be highly visual and contain commissioned clinical review articles enhanced by case work-ups, self-assessment questions and multimedia online elements to provide practitioners with the latest author guided evidence-based information as a tool for day-to-day feline treatment.
‘As a practitioner-orientated organisation we wanted to do more for the vet in practice. So, for ESFM's 10th anniversary we are again breaking the mould by introducing six new issues a year containing well illustrated clinical reviews, aimed specifically at practice, from the best authors around the world,' said Claire Bessant Chief Executive of the ESFM and its founding organisation the Feline Advisory Bureau (FAB).
‘The aim of JFMS ‘clinical' is to turn vision into reality by delivering opinionated reviews, and some ‘outside the box' thinking, from respected clinicians to the front line of veterinary practice,' says JFMS editor Dr Andy Sparkes.
From January, members of ESFM will receive a monthly journal - six classic (the current JFMS) and six JFMS clinical issues - classic and clinical - pure and applied - the best of feline veterinary science.
If you would like a mini-sample of the new journal then contact the FAB/ESFM office Margaret@fabcats.org or go to www.fabcats.org/esfm where you can download a pdf or view it on screen.
Individual membership of ESFM is £110 pa (Euros 145) for UK and overseas. Practice membership is £170 for the UK, £190 overseas (soruE 240). ESFM members are entitled to reduced rates to ESFM congress and gain online access to JFMS papers. Full details are available at www.fabcats.org/esfm.
The RCVS has accredited four more universities to assess modules for its Certificate in Advanced Veterinary Practice (CertAVP). This means that there are now 78 modules for candidates to choose from, with many modules available through more than one university, giving veterinary surgeons a real choice as to how they work towards postgraduate qualifications.
The RCVS CertAVP Subcommittee has approved applications from the Universities of Edinburgh, Glasgow, Liverpool and the West of England (in partnership with Hartpury College).
A very broad range of modules is now available, covering most species and many disciplines. They include some firsts for the CertAVP - equine modules will be available through both Edinburgh and Liverpool universities, and Edinburgh will also be assessing modules in equine dentistry, laboratory animal science and cattle and sheep medicine, amongst others. Glasgow's range includes modules in veterinary public health, as well as emergency critical care, while the University of the West of England's offering includes the key skills modules, and ‘B' modules in small animal, equine and production animal practice.
These universities now join the Royal Veterinary College and the Universities of Cambridge and Middlesex in being accredited to assess modules. While all of the accredited universities provide courses to support candidates working towards modules, including distance-learning options and online support, they must also offer an assessment-only route for those who prefer self-study, or who want to attend courses elsewhere.
The modular CertAVP was launched during 2007 and gives candidates the benefit of a mix and match style of learning. This aims to meet the needs of those who are committed to planned continuing professional development (CPD) but who need to balance this with busy practice life.
The new Certificate also better meets the needs of those whose practice interests change over the enrolment period, or who want to combine study across different species and disciplines to suit their practice caseload. Previously there was little flexibility built into the examination system.
"We are delighted that the list of modules available has nearly tripled this month," says Freda Andrews, RCVS Head of Education. "Interest in the new certificate is growing, and there are already around 200 people enrolled with RCVS for various modules. So it's great news that these universities are now backing the Certificate and enabling much greater choice for veterinary surgeons studying for the qualification."
Full details of the new modules are available on RCVSonline at www.rcvs.org.uk/modcerts
Free-range table-birds being reared from slower growing breeds need a different vaccination regime from that of faster-growing broilers, when being immunised against Gumboro disease.
This previously-unknown fact has emerged from laboratory and field trials, involving several hundred thousand birds on farms throughout the UK, carried out by Lohmann Animal Health in conjunction with poultry vets.
"When using a ‘hot' vaccine conventional broilers in the UK are normally vaccinated at around 14-16 days when their maternal immunity is waning," said Adam Goddard, Lohmann's UK sales consult. "However, we've found this maternal immunity lasts longer in the slow-growing breeds which are reared both indoors and out."
Realistically, the correct day of vaccination for free-range table-birds is more likely to be achieved by using the vaccine date predictions for broiler-breeders, rather than that of the broiler, under the Deventer formula, which gives calculations for different types of bird.
He therefore advises producers to consult their vets who can take blood samples to get an accurate prediction regarding optimum timing of vaccination with their own particular flocks.
"Our trials have shown that, in general, and depending upon the breed used, the decline in maternal immunity is delayed - perhaps for 4-5 days. So, in order to get a better ‘take', we recommend vaccinating these birds later or using an IBD vaccine that ‘takes' in the presence of high maternal immunity." said Mr Goddard.
Gumboro disease - also known as Infectious Bursal Disease - can cause severe losses in chickens and outdoor-reared birds are more susceptible to the disease due to environmental influences.
Earlier this year Lohmann Animal Health launched a new ‘hot' vaccine, classified as an ‘intermediate plus' against the very virulent form of Gumboro disease. The company says that because of its ability to break through high levels of maternal antibodies, it allows vaccination to take place earlier than with other existing vaccines.
VetSurgeon.org member Sam Westhead, a vet from Farnborough, has secured sponsorship from Vets Now and Vet Times in his entry to the grueling Ironman 70.3 World Championship challenge in Clearwater in Florida this November
The two organisations will each sponsor Sam £250 for taking part in the challenge.
Sam, who works at Grazely Vets in Farnborough, qualified for the World Championship event earlier this year in the Singapore Ironman 70.3, coming first in the veterans group and a not too shabby 30th overall!
Clearly not for the faint hearted, the Ironman 70.3 World Championship consists of a 1.2 mile swim, a 56-mile bike and a 13.1 mile run, adding up to 70.3 miles of total racing.
Speaking about his entry to the race, Sam commented; "The training is going well and I'm trying to focus on keeping up the momentum and enthusiasm for the race as the countdown is now on! I'm obviously looking forward enormously to arriving in Florida in a few weeks time and competing in the event - it's a real achievement to have got to this stage. I would like to say a big thank you to Vets Now and the Vet Times for their extremely kind donations which will go some way to covering the cost of my flights to and from the event."
Richard Dixon, Group Managing Director for Vets Now said; "Sam is an extremely dynamic individual who displays wonderful passion for both his career and in living life to the full. I know he has trained hard to qualify for the event and to get to this stage and Vets Now is delighted to be backing Sam in this particularly grueling and ambitious challenge. We wish him well in his final few weeks of training and of course in the event in November."
From 31 October 2008, veterinary surgeons will again be allowed to charge animal owners for writing prescriptions, when a three-year ban on such fees comes to an end.
The Supply of Relevant Veterinary Medicinal Products Order 2005 was introduced by the former Department of Trade and Industry (DTI) to implement recommendations from a 2003 Competition Commission inquiry into the supply of prescription-only veterinary medicines, which, among other things, found that prescription charges were against the public interest. It was hoped by the DTI that the move would benefit consumers by providing for pharmacies and other suppliers to have an opportunity to establish themselves as competitors to veterinary surgeons in supplying prescription-only veterinary medicines.
Although veterinary practices will be able to make a charge for writing a prescription from 31 October 2008, one thing does not change: practices must not charge different fees for other services or veterinary medicines to those who take a prescription and those who do not.
Jill Nute, RCVS President said: "The OFT (Office of Fair Trading) will monitor the reintroduction of prescription charges and has indicated that the level of monitoring will be proportionate to the perceived need - how well the market is working.
In addition, the RCVS will monitor complaints that relate to prescription charges and meet with the OFT to review the situation in six months time. Care must be taken to ensure that prescription fees are calculated sensibly, or the zero-fee ruling may be reintroduced."
The OFT has advised that veterinary practices must not agree between themselves what constitutes a suitable fee: it is prohibited by competition law.
General guidance for members of the profession is available on RCVSonline (Advice Note 15): www.rcvs.org.uk/advicenotes. Guidance for members of the public is also available online at:
http://www.consumerdirect.gov.uk/before_you_buy/thinking_about/560042/
Other Competition Commission recommendations, such as displaying a price-list of the ten relevant veterinary medicinal products most commonly prescribed during a recent period, have been enforced since 2005 via the RCVS Guide to Professional Conduct and will remain in place.
Some interesting statistics from insurers Petplan today. Turns out that almost a third of 3000 pet owners surveyed by the company admitted accidentally injuring their pet, resulting in an average vet bill of £170.
Nearly 6 out of 10 owners admitted stepping on their pet, while 21% confessed to dropping them. The next biggest threat posed to pets by their owners was accidental poisoning.
The survey found that dogs are most likely to be stepped on, whilst guinea pigs are most likely to be dropped by their overly affectionate owners.
The survey also found that 1/3rd of pets hurt themselves jumping off furniture, and one in five have been injured running in front of a car.
More than a third of pets injure themselves eating something they shouldn't, including the dog that swallowed a pair of knickers, which ended up costing £1,200 to retrieve.
Intervet/Schering-Plough Animal Health, has launched a new guide entitled ‘Your guide to Exotic Diseases', to educate horse owners on these potentially fatal, insect-borne diseases, some of which are zoonotic.
Joining the company's guides on respiratory disease and vaccination, the leaflet features information on West Nile Virus, African Horse Sickness, Equine Infectious Anaemia (Swamp Fever) and Equine Encephalitis including overviews of each of the diseases and their clinical signs.
Spread by a variety of insect-borne vectors including midges, mosquitoes and horseflies, climate change is increasing the risk of exotic diseases having a severe impact on the country's equine industry. What's more, African Horse Sickness is transmitted from animal to animal by infected biting Culicoides midges, the same midges that carry the Bluetongue virus which has threatened UK livestock this year.
"It's essential that horse owners are aware of the threat of exotic diseases coming in from overseas and the clinical signs to look out for, especially during the summer and autumn months when diseases transmitted by insects are more likely to appear." comments Tim Zoch, Marketing Manager at Intervet/Schering-Plough Animal Health. "Our new leaflet features easy-to-understand overviews of each of the diseases to help educate owners, and practices can expect strong demand from their clients"
For further information about Intervet/Schering-Plough's range of horse owner guides, including ‘Your guide to Exotic Diseases', please contact your Intervet/Schering-Plough Account Manager or call the Veterinary Support Group on 01908 685685.
ECM of France, a specialist in veterinary ultrasound solutions, has launched VIRTUAL SCAN - an ultrasound scanner for pig farmers and veterinarians. ECM says the scanner offers an alternative to screenless A-Mode Doppler devices, cheaper ultrasound devices, which are often poor quality.
VIRTUAL SCAN weighs 450 grams. It is equipped with an internal five-hour battery and a 5MHz sector probe. ECM says the instrument is extremely easy to handle - all the user needs to do is switch it on and the hand-held instrument is instantly ready to perform an ultrasound on sows.
VIRTUAL SCAN is a compact device (11cm x 18.5cm x 4.5cm) and does not require an external cable. According to the company, it can be used in any livestock facility, even inside narrow, hard-to-reach stalls. The screen is positioned in such a way that the image is always visible.
Using ECM's scanner, pregnancy tests can be performed as early as 21 days after insemination, so it is possible to re-inseminate any unfertilised sow without wasting a costly additional cycle. The image is easy to interpret. After use, the VIRTUAL SCAN ultrasound instrument is easy to clean with a damp cloth or water.
ECM, which is headquartered in Angoulême (in south-western France), develops and manufactures specialist veterinary-science devices. The company also provides training in ultrasound techniques, the correct way to move the probe and how to interpret the ultrasound image.
For more information, please contact:
Simon QuarmbyHOLMEFIELD Farm ServiceAgriculture HouseMurton LaneMurtonYorkT019 5UF
tel : (44) 1904 481.490fax : (44) 1904 481.211email : simon@hfsvets.com
Or visit: http://www.agroscan.com/ and http://www.ecmscan.com/
Fort Dodge Animal Health has announced it is working with the authorities to put measures in place to make its West Nile Virus vaccine, licensed in the United States, available to the European equine market. These measures will ensure a vaccine is readily available in the event of an outbreak in the UK.
This news comes as the Zooprophylactic Institute of Teramo, the Italian National Reference Centre for Exotic Diseases, has confirmed an outbreak of WNV among horses in stables in the northern province of Ferrara. About 20 horses are believed to have been affected.
Fort Dodge was the first company to develop and fully license a vaccine to protect horses against this potentially deadly disease. An inactivated whole virus vaccine, it was the only vaccine available in the United States at the height of the 2002 outbreak, which affected 15,000 horses. The U.S. Department of Agriculture credited the vaccine with contributing to the 70 per cent decline in U.S. equine West Nile cases since the height of the outbreak. WNV is now considered endemic in all areas of North America.
"As this latest outbreak of WNV in Italy highlights, the disease presents an increasing threat to the equestrian sector in Europe," says Helen Barnes, EMEA Equine Business Manager for Fort Dodge. "With little current natural immunity among the equine population, the consequences of a major outbreak could be devastating."
"Until now, horse owners in Europe have perhaps believed WNV is not a disease they should be concerned with but the outbreak in Ferrara came out of the blue, and at a time when a human case of WNV was also reported in the same province. This situation of both human and equine cases being reported is identical to that seen in the outbreaks in the United States. It's a stark reminder of the challenge this disease poses, particularly as environmental factors, such as global warming and heavy rains threaten to create mass breeding grounds for mosquitoes," says Barnes.
"Our experience with WNV in the United States has given us an exceptional understanding of the disease and the importance of vaccination. We now look forward to working in partnership with the European governments, the EU Commission and the veterinary community across Europe to help build understanding and knowledge of this dangerous emerging disease threat."
Animalcare has launched Buprecare into the UK and Ireland veterinary markets. Buprecare (POM-V) is a veterinary licensed analgesic, containing buprenorphine, for use in dogs and cats. It is licensed for post-operative analgesia in dogs and cats, and potentiation of the sedative effect of centrally acting agents in dogs.
This is the second major product the company has introduced in the last 18 months as Animalcare continues to grow its portfolio of veterinary products with the launch of an ACE inhibitor Benazecare (benazepril hydrochloride) earlier in 2007.
To complement the product launch, Animalcare is offering an ampoule breaker to help practice staff to open ampoules safely, together with a practice support package, containing pain scoring pads to aid in the assessment of pain of patients and judging of adequate analgesia requirements. In addition a dosing table and poster detailing common behavioural changes that can be associated with pain are available. Buprecare 0.3mg/ml is available in 1ml ampoules, in cartons of 5 ampoules.
Stephen Wildridge, Managing Director of Animalcare Ltd. said: "We have a very exciting time ahead with the launches of several new pharmaceutical products over the next twelve months, and the proposed expansion of our business into the major European veterinary markets."
Please contact your Animalcare representative, or ring 01904 487687 for more details.
Vetoquinol has announced the winners of the 2008 Marbocyl Achievement Awards. Six veterinary schools took part in the award scheme, which enabled them to recognise the achievements of either staff or students, with a prize fund of £2000 for each university.
Five of the vet schools have announced their 2008 winners, the University of Liverpool will announce its winners in January 2009. Those who have already received their awards this year are:
University of Bristol Dr Catherine Fuller, MRCVSMs Kathryn Murphy, MRCVSMichael Steele, MRCVSChristopher Hudson, MRCVSSamantha Taylor, MRCVS
All of the winners are members of staff nominated by their students for excellence in teaching.
University College DublinDr Carmel Mooney, MVB MPhil PhD DECVIM-CA MRCVS, for an outstanding performance as Clinical Director of the Veterinary Hospital at UCD.
University of CambridgeAdrian Wallace, BVSc (Hons), MACVSc (SAS), MRCVS for his clinical research paper , ‘A biomechanical comparison of six double-loop configurations for use in the lateral fabella suture technique for the cranial cruciate ligament deficient canine stifle', Journal of Veterinary and Comparative Orthopaedics and Traumatology, 2008. Catherine Stalin, MA, VetMB, MRCVS for her paper ‘Radiographic morphology of the cranial portion of the cervical vertebral column in Cavalier King Charles Spaniels and its relationship to syringomyelia', American Journal of Veterinary Research, 2008 Penny Watson, MA, VetMB, CertVR, DSAM, Dip ECVIM, MRCVS, European Specialist in Small Animal Medicine for her clinical research paper ‘Prevalence and breed distribution of chronic pancreatitis at post-mortem examination in first opinion dogs' Journal of Small Animal Practice, 2007.
University of GlasgowMark Lowrie, MA VetMB MRCVS, for his Clinical Research Abstract - "Acute phase proteins and immunoglobulin A in steroid responsive meningitis-arteritis"
Royal (Dick) School of Veterinary Studies EdinburghLesa Longley, MA BVM&S Cert ZooMed MRCVS for an exceptionally high level of achievement during her residency programme.
Mark Leddy, Vetoquinol's Marketing Department Manager said: "We are delighted to have been able to help these universities recognise and reward the achievements of staff and students over the past three years."
According to the European Scientific Counsel for Companion Animal Parasites (ESCCAP), serious zoonotic diseases, currently rife across Europe, could be a far more serious threat to pet and human health in the UK than official figures suggest.
Vets and parasitologists at an ESCCAP meeting held in Bristol on 19th September, heard evidence that UK cases of diseases such as leishmaniosis and babesiosis are grossly under-reported. ESCCAP is urging vets and parasitologists to help raise awareness of the threat and lobby the Government to prevent further relaxation of pet movement restrictions.
According to DACTARI, the voluntary web-based Dog And Cat Travel And Risk Information scheme, just 19 cases of leishmaniosis, 10 babesiosis, 10 ehrlichiosis and one case of dirofilariosis had been recorded between 1 January 2003 and 30 September 2006, which are the latest figures reported on the Defra website.
But latest figures presented by Susan Shaw, senior lecturer in dermatological and applied immunology, revealed a screening programme underway at Bristol University casts serious doubts on the reliability of the Defra-backed service to monitor cases.
"From 2005 to 2007 we recorded 257 cases of leishmaniosis. The babesiosis cases you can multiply by about five, the ehrlichiosis cases by about 10 and dirofilariosis by three," Ms Shaw told delegates at the sixth ESCCAP meeting. "That is absolutely outrageous - we are dealing with a massive number of cases. I would be very concerned if we are making decisions for the UK based on the DACTARI figures."
Maggie Fisher, an independent consultant in veterinary parasitology and founding member of ESCCAP pointed out that the PETS (Pet Travel Scheme), has issued dogs and cats with passports for travel across Europe since 2000 and has proven immensely popular, with 76,000 dogs entering the UK in January to October 2007 alone.
"What is coming into the country with those animals is not well documented," said Mrs Fisher. Case studies point to harrowing experiences for individual families travelling with their dogs to mainland Europe unaware of the dangers. "One family thought they'd done everything they should because they followed the instructions under PETS. What they didn't realise is that they weren't protected against ticks, tick-borne diseases and worms whilst they were away and their dog picked up babesiosis."
Human health and veterinary professionals at the meeting explored the real threat and implications of parasites across Europe. Peter Deplazes of ESCCAP, Switzerland, reported that the human form of Echinococcus multilocularis claims three or four lives per year in Switzerland and is a very common endoparasitic diagnosis in dogs. Forty per cent of foxes are infected with E multilocularis.
Leishmaniosis causes renal failure in dogs, reported ESCCAP Spain's Lupe Miro Corrales, often leading to death or euthanasia. Worldwide more than 12 million people are already infected, and one in ten at risk of being infected. Stray dogs and cats are important carriers and almost 80 per cent of sero-positive dogs have no clinical signs.
Natural controls offered by the UK's island status are now under threat. Currently a derogation allows the UK, and four other EU member states, stricter controls to help maintain their Echinococcus multilocularis and tick-borne disease free status. It extends to July 2010 but comes up for review next year, pointed out Maggie Tomlinson from the Department of Health, who is taking the case to the EU Commission.
"I can say categorically that they are not keen for us to keep the derogation and it's going to be a very hard fight. We only have until January to push the Commission to make a decision."
Chairman-elect of ESCCAP Europe, James Duncan, pointed out the organisation is seeking to raise awareness of the serious risks posed by endo and ecto-parasites to human and animal health, and is developing independent guidelines and educational materials for their optimal control.
"There is no immediate panacea," he said. But those in the veterinary profession who are aware of the risks should take action. "It is up to you to lobby - put your voice to Government and influence the pet passport scheme. You can do that and it will help our cause because we are singing from the same hymn sheet."
If you had purchased £1000 of Northern Rock shares one year ago they would now be worth £4.95; with HBOS, earlier this week your £1000 would have been worth £16.50; £1000 invested in XL Leisure would now be worth less than £5; but if you bought £1000 worth of Tennents Lager one year ago, drank it all, then took the empty cans to an aluminium re-cycling plant, you would get £214.
So based on the above statistics the best current investment advice is to drink heavily and re-cycle.
The European Advisory Board on Cat Diseases (ABCD) has issued new guidelines concerning rabies in cats.
The organisation, which is made up of 17 independent veterinary experts, meets 3 times a year to discuss major infectious feline diseases. The rabies guidelines are the latest in the series, which are available for download at: http://www.abcd-vets.org/guidelines/index.asp
Dunfermline-based Vets Now Ltd has been announced as the winner of the Scotland regional final of the £35 Million Bank of Scotland Corporate Entrepreneur Challenge. The company, based on Pitreavie Drive, is the UK's leading provider of out of hours emergency care for animals and has secured an incredible funding package of up to £5 million, free of interest and charges for three years, to turn their expansion plans into reality.Richard Dixon, Managing Director of Vets Now Ltd, said, "I am absolutely thrilled that we have won the Scottish regional final of the Entrepreneur Challenge. A lot of time and effort went into our presentation and we knew that the competition was going to be tough. I'm very proud of our team, without who Vets Now would not be what it is today."Winning the Challenge is going to have a fundamental impact on Vets Now, taking our business to a completely new level. The funding will allow us to make substantial growth and move the business into Europe. It will also increase the range of services we can provide to customers and increase the overall profile of our organisation."Richard will now go through to the national final in December, where he will compete against the winners from six other regions across the UK for the chance to be named ‘Entrepreneur of the Year' and the opportunity to benefit from four days mentoring from one of Britain's most successful and high profile entrepreneurs.Vets Now was chosen as the winner after Richard Dixon presented his business case and plans for the future to a panel of judges, including Willie Haughey from City Refrigeration and John Anderson from The Entrepreneurial Exchange. Willie, John and the rest of the judging panel then questioned Richard in their search for an entrepreneur who displayed flair, vision and creativity, coupled with solid business acumen and impressive plans for the future. The judging was followed by a dinner and award ceremony at Stirling Castle, at which the winner was announced.For more information visit http://www.theboschallenge.co.uk/
The Animal Medicines Training Regulatory Authority (AMTRA) is launching its new Continuous Professional Development (CPD) scheme today, designed to ensure that the Authority's registered Suitably Qualified Persons (SQPs) keep up to date with the latest animal medicines information.
In order to maintain their SQP status, every SQP will have to achieve a minimum number of CPD points during each AMTRA CPD period, running for two years from July to June. However, in the initial stages of the scheme, this first period will run for 33 months, from October 2008 to June 2011, allowing AMTRA to fine tune the system if required and give its SQPs time to get used to the new structure.
During these CPD periods, SQPs are required to obtain a minimum number of CPD points depending on their SQP type:
SQP Type: Modules; VPS medicines supplied; CPD PointsR-SQP: FAM+EQM+CAM; All VPS Medicines; 70 pointsG-SQP: FAM+EQM; VPS-farm animals and equines only; 50 pointsK-SQP: FAM+CAM; VPS-farm and companion animals only; 50 pointsE-SQP: EQM+CAM; VPS-equines and companion animals only; 50 pointsL-SQP: FAM; VPS-farm animals only; 30 pointsJ-SQP: EQM; VPS-equines only; 30 pointsC-SQP: CAM; VPS-companion animals only; 30 points
(FAM - Farm Animal Module, EQM - Equine Module, CAM - Companion Animal Module)
In essence, this means that 20 points are required per animal group, plus a further 10 points. Dr Roger Dawson, Secretary of AMTRA comments, "There is no maximum number of CPD points that SQPs can accumulate and we will be encouraging them to gain the benefit of as much CPD as they can."
Those SQPs who do not achieve the minimum number of CPD points by the end of the period will not be eligible to renew their status for the following year. However, such SQPs will have the option of sitting an examination before the end of that CPD period in order to maintain their SQP status and eligible be to renew for the next year.
SQPs will have a range of avenues through which to gain CPD points, ranging from four types of AMTRA-accredited CPD Events, to online study and personal study. With CPD Events and online studies, accreditation and points will be awarded by the AMTRA CPD Accreditation Panel. With personal study, AMTRA accepts a degree of self-certification of this form of CPD, however the points gained in this way are limited to a relatively small proportion of the minimum required in a CPD period.
Throughout a CPD period, all SQPs are required to attend at least ONE CPD Event. These events will comprise a range of modules that will be assessed for coverage, of relevant topics ranging from legislation, regulations and prevalence & effects of parasites and pathogens, to control of disease management, resistance, warnings and SARS.
Dr Dawson says, "The new CPD scheme has the necessary flexibility to allow SQPs to gain the required CPD points via a number of routes, from accredited CPD events and online study to personal study. Furthermore, the structure of the scheme ensures that their studies will be properly assessed to ensure they have gained the necessary knowledge to secure their CPD points."
Cystease® S, CEVA Animal Health's urinary tract support product for cats, is now available in a new 100 tablet pack size for greater convenience to the practice.
CEVA`s small animal veterinary advisor Fraser Broadfoot said: "Previously Cystease® S was only available in 300 tablet packs. The new 100 tablet pack size makes the product easier to store in the practice and easier to dispense to clients."
To help vets gain easy access to information on Feline Lower Urinary Tract Disease (FLUTD), CEVA Animal Health have also produced a highly informative technical review on the subject. Produced in conjunction with Professor Danielle Gunn-Moore, head of the feline clinic at the University of Edinburgh, the eight-page, colour brochure contains practical information on the clinical signs, diagnosis and treatment of FLUTD and also includes behavioural advice on reducing stress in cats, which can be a major cause of FLUTD.
To receive a free copy of CEVA's FLUTD technical review and for further information on Cystease® S, please contact Fraser Broadfoot MRCVS on 01494 781510, CEVA Animal Health Ltd, 90 The Broadway, Chesham, Bucks, HP5 1EG.
The British Veterinary Association has welcomed the British Veterinary Nursing Association and the Veterinary Practice Management Association as Affiliate members.
Affiliate and Associate are newly activated BVA membership categories, and the election of BVNA and the VPMA as Affiliates also encourages any of their suitably qualified members to apply for Associate membership of the BVA.
According to the BVA, Affiliate status in no way affects an organisation's own remit and responsibilities towards its members. What it does mean is that Affiliates can benefit from the BVA's knowledge and expertise in such areas as lobbying and marketing.
In welcoming BVNA and VPMA newly elected BVA President Nicky Paull said: "I am delighted that my Presidential year coincides with the BVA family embracing both veterinary nurses and veterinary practice managers. Both are integral members of the veterinary team and we believe that our new relationship will bring lasting benefits to all parties. BVA looks forward to supporting our new Affiliates in promoting the professionalism of both veterinary nursing and veterinary practice management not only within the profession but to the wider community.
These are exciting, if challenging times, for the veterinary community world-wide and I have no doubt that our new relationship will strengthen not only our individual associations but the profession as a whole."
A new guide - written by a vet and for vets - looking at the causes and treatment of pituitary tumours in rats has been produced in conjunction with the UK's first dedicated pet rat rescue charity, CavyRescue.
Written by exotics certificate holder Mark Rowland BVSc CertZooMed MRCVS, the guide discusses the illness as well as suggests treatments, many of which are not routinely used in the treatment of this condition.
Stella Hulott from the charity said: "Over the last ten years' one of the most common questions we, as a high profile pet rat rescue, get asked about is pituitary tumours in rats. The symptoms can be disturbing and not often attributed to the real cause.
"To date there has been very little information available about pituitary tumours in rats, so we felt the need to share our vet's knowledge in order to help reduce the amount of unnecessary suffering caused by this sadly very common illness."
The guide will be emailed out to those veterinary practices that have email access. Alternatively, you can download it here: http://www.cavyrescue.co.uk/pituitary-tumours-in-rats.pdf
It's National Veterinary Nurse Week from 26th October to 1st November and vet nurses across the country will be raising awareness of the important job they do in caring for the nation's pets. Bonny Millar CVT(USA), RVN, REVN, Vice President of the BVNA and VN week organiser has called for vets and practice managers to support the initiative.
She said: "This is an ideal opportunity for practices to use their nurses to full effect. A lot of our efforts go on behind the scenes and so nurses are sometimes not fully appreciated by pet owners. We are encouraging practices to get their nurses out at front of house, running clinics and offering clients help and expert advice. Reducing barriers and educating the wider public about the role of the vet nurse can only be a good thing. Vets and practice managers know what a great contribution a good vet nurse can make to the practice and we would love to see them make a big effort to be ‘loud and proud' during National VN Week."
Bonnie added: "Last year hundreds of veterinary nurses took part in VN Week and we raised over £5000 for charity. This year our nominated charity is the Animal Cancer Trust so I hope practices really support their nurses in helping raise money for this important cause."
The British Veterinary Nursing Association is co-ordinating the various activities going on around the country and has arranged two pet health check days in Roundhay Park in Leeds on 26th October and Kensington Gardens in London on 1st November, sponsored by Hill's Pet Nutrition. Nurses are also being encouraged to make a special effort with prizes on offer thanks to sponsors Animalcare (Satellite Navigation system), Merial (lap top) and Vetoquinol (Nintendo Wii) for the most innovative event, most public involvement and most money raised for charity.
Further information and a registration pack is available from the BVNA http://www.bvna.org.uk/ (Tel 01279 408644). Any members of the practice interested in keeping up to date with the activities planned for VN Week can also visit the blog for the event at http://vnweek.wordpress.com/
Bayer Animal Health has launched Renalzin®, a feed additive for the management of Chronic Renal Disease (CRD), the leading cause of morbidity and mortality, especially in older cats1.
One-third of all cats over 15 years of age have CRD2, but the disease often remains undetected until the cat suddenly falls ill, by which stage 85% of kidney function may have already been lost3. The clinical signs are often subtle and non-specific, and diagnosis is complicated by the fact that changes in laboratory values occur relatively late in the disease.
Dr. Dennis Chew, specialist in veterinary urology and nephrology at the Ohio State University, said: "Most veterinary surgeons understand that CRD affects many cats, especially as they age, and is a leading cause of death. CRD is difficult to identify in early stages - early intervention with treatment can prevent progression of CRD to those with more serious kidney deficits. Restriction of dietary phosphorus intake is known to be a pivotal beneficial step in the stabilisation of CRD. Renalzin is a paste specifically formulated for cats that prevents dietary phosphate absorption across the intestine - a beneficial effect is gained when added to the cat's normal diet or to a veterinary renal diet".
The main ingredient of Renalzin is Bayer-registered Lantharenol® (lanthanum carbonate), a phosphate binder which binds to dietary phosphate within the gastrointestinal tract. According to the company, this renders it indigestible and thereby eases the burden on the already damaged kidneys.
Renalzin contains two additional ingredients - kaolin and vitamin E. Kaolin is a toxin binder which helps to reduce the absorption of toxins from the gastrointestinal tract. Vitamin E is known to reduce free radicals, improving immunity and protecting the integrity of cell membranes.
Bayer says that clinical studies demonstrate that Renalzin significantly increases faecal elimination and decreases urinary excretion of phosphorus 5. The product also decreases phosphate digestibility (absorption) in cats that are on both high and lower phosphate diets6. In addition, studies have shown that Renalzin causes a decrease in serum phosphate levels in cats with standard maintenance diets non-restricted in phosphorus7. Finally, a clinical trial in feline CRD patients revealed that taking Renalzin resulted in improvements in general clinical examination parameters as assessed by their veterinary surgeons over a two month period in cats on a normal diet7.
Renalzin comes in a pump applicator. One pump action provides 1 ml, with 2 ml being the recommended daily dose applied to and/or mixed with the cat's food. Having a neutral taste and being odourless, Renalzin® does not change the flavour of the cat's food and is flexible for clients to use as it can be given once or twice daily depending on the cat's feeding pattern.
References1 Lulich JP, O'Brien TD, Osbourne CA, Polzin DJ. Feline renal failure: questions, answers, questions. Cd Cont Ed Pract Vet 1992, 14(2): 127 - 151.2 Polzin DJ, Osbourne CA, Adams LG, Lulich JP. Medical management of feline chronic renal failure. In, Bonagura JD, Kirk RW (eds). Current Veterinarian Therapy X1. Philadelphia, PA, Saunders, 1992: 848-853.3 Grauer GF. Early detection of renal damage and disease in dogs and cats. Vet Clin Small Animal 2005, 35: 581-596.4 http://en.wikipedia.org/wiki/Lanthanum_carbonate.5 Schmidt B et al Bay 78-1887, J Vet Pharmacol Therap 2006, 29 (Suppl 1): 206-2076 Schmidt B, Spiecker-Hauser U, Gropp J. Effecrt of Lantharenol® on apparent phosphorus absorption from a conventional feline maintenance diet and a renal diet for cats. Proc Soc Nutr Physiol (2008) 17, in press.7 Data submitted for publication.
Vets Now Limited, the out-of-hours emergency care provider, has been announced as a finalist in the Scottish region of the Bank of Scotland Corporate £35 Million Entrepreneur Challenge. The company will now compete with four other businesses to secure a funding package of up to £5 million, free of interest and charges for three years.
Managing Director, Richard Dixon, must now present his business case to a judging panel featuring two well known and incredibly successful entrepreneurs. Willie Haughey from City Refrigeration and John Anderson from The Entrepreneurial Exchange will be joined on the panel by senior representatives from Bank of Scotland Corporate and Deloitte. The panel will be grilling all five finalists on their future business plans, as well as looking for someone with an entrepreneurial flair, spirit and vision that sets them apart from the rest and makes them an outstanding choice to receive the once in a lifetime funding package that could change the face of the business.
The judging process will take place on Thursday 2 October and will be followed that evening by a dinner and award ceremony at Stirling Castle, where the winner will be announced.
For more information visit http://www.theboschallenge.co.uk/